- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Marc-Andre Cornier on the Genetic Risk for Obesity
Marc-Andre Cornier, MD, professor and director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina, describes the genetic factor that contributes to obesity risk.
Although individuals can't alter their genetics, they can alter their environment, said Marc-Andre Cornier, MD, endocrinologist, professor, and director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina.
Transcript
What does it mean to be prone to obesity?
We believe that there's a genetic component to the risk for obesity. The way to think about it is the opposite. There are people in our environment who are lean, normal weight, thin, and there's very strong genetics for that as well. And so it's our belief that people are either prone to weight gain or not, and in the right environment, that leads to weight gain and obesity. So that might be, you know, differences in physiologic markers that relate to body weight regulation; it could be differences in signaling in the brain.
There's not one specific thing that says this is what makes the person prone to to gain weight. But we clearly see familial patterns to this. There's clearly genetic components to the risk for obesity. And so we like to think about it as potential proneness or genetic risk. Can you alter that? Yes, by altering the environment. You can't change genetics, you can't change your own baseline physiology, but you can change your environment and that's what we have to work on.
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
